Private Wealth Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Buy
3,380
+293
+9% +$141K 0.16% 92
2026
Q1
$1.52M Buy
3,087
+8
+0.3% +$4.34K 0.16% 95
2025
Q4
$1.78M Sell
3,079
-6
-0.2% -$3.39K 0.19% 79
2025
Q3
$1.5M Sell
3,085
-213
-6% -$99.1K 0.18% 86
2025
Q2
$1.34M Sell
3,298
-443
-12% -$185K 0.18% 90
2025
Q1
$1.86M Buy
+3,741
New +$2.03M 0.27% 64

Other funds holding TMO

Private Wealth Asset Management's TMO Position: Q2 2026 in Review

Private Wealth Asset Management increased its Thermo Fisher Scientific (TMO) stake by 9.5% in Q2 2026, buying an estimated $141K and bringing the position to 3,380 shares worth $1.69M. The position accounts for 0.16% of the portfolio, ranked #92.

Private Wealth Asset Management first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.86M in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Private Wealth Asset Management held 3,380 shares of Thermo Fisher Scientific worth $1.69M as of Q2 2026.
  • Private Wealth Asset Management bought 293 Thermo Fisher Scientific shares in Q2 2026, an estimated $141K.
  • Thermo Fisher Scientific made up 0.16% of Private Wealth Asset Management's portfolio in Q2 2026, its #92 holding.
  • Private Wealth Asset Management first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • Private Wealth Asset Management's Thermo Fisher Scientific position peaked at $1.86M in Q1 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.